Supporting Global COVID-19 Efforts
Testing can make all the difference
COVIDSeq, the first diagnostic NGS test to receive emergency use authorization from the FDA.
In sequencing SARS-CoV-2 strains, Dr. Chiu could have keys to the disease
When UCSF's Charles Chiu was tapped by the CDC to sequence viral strains from throughout California, he knew he needed more capacity.
Dr. Bedford helps trace and halt community spread in Washington
With the help of Illumina NextSeq 550 and reagents, Dr. Bedford was able to identify one of the first COVID-19 clusters in the US.
How Illumina NGS can help identify and track SARS-CoV-2
Illumina has developed two workflows to detect and track SARS-CoV-2 from clinical samples.
From identification to vaccine development to outbreak control
NGS has the unique ability to support scientists, researchers, public health officials and health care professionals on the front lines. It helps us understand transmission routes, comorbidities, mutation rates, serves as a foundation for vaccine development and therapies, and ultimately helps predict and prevent future outbreaks.
Learn More from CMO Phil Febbo
Connecting those who look for answers with the technology to find them
We believe access to the best technologies, global networks, and genomic insights are crucial to stop this pandemic and keep it from coming back. This is why we work with researchers, the CDC, the Chinese CDC, the NIH, GISAID, Stanford, the Broad Institute, and more to make sure they have the support they need to succeed.
Read COVID-19 Stories
Global needs are our responsibility
We are a global company championing the greater good, committed to supporting COVID-19 efforts around the world. We are proud to partner to fund the Africa Centre of Excellence for Genomics of Infectious Diseases as well as the Milken Institute to develop global surveillance networks.
Our unique ability to help
With our decades of experience, vast global reach, support across countries and languages, as well as data transparency, we are afforded a humbling opportunity to quickly connect and support local and global resources to fight this pandemic across the world.
How We Support the Fight Against COVID-19
Global
Illumina makes software toolkit available free of charge to support worldwide efforts to combat COVID-19
Read MoreAfrica
An Illumina Donation to the African CDC Expands their Capability for Sequencing-Based Surveillance
Read MoreChina
Providing the system used to sequence the first SARS-CoV-2 genome in Wuhan
Cambodia
iSeq 100 System + iSeq cloud metagenomic platform allow characterization of SARS-CoV-2 in Cambodia
Read MoreIllumina COVID-19 Workflow Overview
Manage Workflow
Prepare Library
Sequence
Analyze
Collaborate
Key Solutions
Shotgun Metagenomics
Allows researchers to identify novel pathogens and helps accelerate outbreak investigations.
Respiratory Pathogen Enrichment
Detects SARS-CoV-2 as well as common respiratory pathogens, and provides information about epidemiology and evolution.
Illumina COVIDSeq Test
This high-throughput NGS test detects RNA from the SARS-CoV-2 virus.
Join the conversation
Register now for a conversation with former U.S. FDA Commissioner Dr. Scott Gottlieb: “Genomics’ Role in Global COVID-19 Surveillance”.
Register Now
COVID-19 Resources
- www.cdc.gov/coronavirus/2019-ncov/communication/guidance-list.html
- www.coronavirus.gov
- www.mayoclinichealthsystem.org/covid19
- www.nih.gov/health-information/coronavirus
- www.fda.gov/medical-devices/emergency-situations-medical-devices/faqs-emergency-use-authorizations-euas-medical-devices-during-covid-19-pandemic